Federal contract award
N3239824P0051
DLO-FB1-2 DUAL-LABELED PROBE, 5' FAM/3'
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NAVAL MEDICAL RESEARCH CENTER |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $63.0K |
| Current contract value | $63.0K |
| Potential contract value / ceiling | $63.0K |
| Start date | Sep 11, 2024 |
| Current end date | Dec 31, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Oct 22, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 22, 2025 | P00004 | $0 | REMOVAL OF THE UID EXEMPTION INDICATOR FROM CLINS 0017, 0019, 0021 AND 0030 SO THE INVOICE CAN UPLOAD IN WAWF FOR PO N3239824P0051. SEE ATTACHED CONFORMED COPY FOR SUMMARY OF CHANGES. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Sep 25, 2025 | P00003 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO INCLUDE THE TYPE OF INVOICE AS COMBO INVOICE IN CLAUSE 252.232-7006 WAWF PAYMENT INSTRUCTIONS FOR PO N3239824P0051. SEE ATTACHED SUMMARY OF CHANGES. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Aug 19, 2025 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO INCLUDE THE TYPE OF INVOICE AS COMBO INVOICE IN CLAUSE 252.232-7006 WAWF PAYMENT INSTRUCTIONS FOR PO N3239824P0051. SEE ATTACHED SUMMARY OF CHANGES. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Oct 22, 2024 | P00001 | $0 | DLO-FB1-2 DUAL-LABELED PROBE, 5' FAM/3' |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.